You are here: Home » Companies » News
Business Standard

Apollo Hospitals scouting for acquisitions in north and east India

The hospital chain recently got its board's approval to raise up to Rs 1,500 crore and a portion of it will be used for acquisitions

Topics
Apollo Hospitals | Indian healthcare

TE Narasimhan  |  Chennai 

Apollo Hospitals
Suneeta Reddy, Managing Director, Apollo Hospitals Group said that while they may not look for greenfield projects for the time being, they are looking at a few small ticket acquisitions

After acquiring IHH Healthcare (IHH’s) stake in Apollo Gleneagles Hospitals, Kolkata (AGHL), Chennai-based is now scouting for some more acquisitions in north and east India. The hospital chain recently got its board’s approval to raise up to Rs 1,500 crore and a part of it would be funded for acquisitions.

According to Suneeta Reddy, managing director, Group, they may not look for greenfield projects now, but they are looking at a few small-ticket acquisitions (like 300 beds in larger cities and 200 beds in smaller ones) to expand its presence mainly in the north and eastern parts of the country.

Recently, Apollo signed a definitive share purchase agreement with IHH, its JV partner in Apollo Gleneagles Hospitals, Kolkata, to acquire its existing 50 per cent stake in AGHL for a cash purchase consideration of Rs 410 crore.

She said the proposed qualified institutional placement (QIP) would fund acquisitions for investment in 24/7 app and to reduce debt to enhance profitability. Apollo got its board’s approval to raise up to Rs 1,500 crore on preferential basis or through QIP.

Krishnan Akhileswaran, group chief financial officer, Apollo Hospitals, said occupancy in November increased to 70 per cent from 65 per cent in October. It was 38 per cent in the first quarter. He said the break-even is around 50 per cent. The Covid-19 occupancy is 30 per cent of the total occupancy.

On pharmacy, he said 80 per cent Ebitda would be captured by back-end operations of Apollo Hospitals, and once the initial costs are absorbed the back-end operations can capture 85 per cent of the Ebitda of its pharmacy business.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, November 19 2020. 10:25 IST
RECOMMENDED FOR YOU
.